Marrone Bio Innov (MBII)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.7981 -0.2019 (-20.19%) 07/12/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.7981 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,554 | -20,168 | -37,175 | -20,213 | -30,925 |
| Depreciation Amortization | 4,567 | 4,365 | 3,154 | 1,890 | 2,044 |
| Accounts receivable | -3,098 | -4,188 | -2,622 | 1,065 | -193 |
| Accounts payable and accrued liabilities | 585 | -1,409 | 1,204 | -2,028 | 2,305 |
| Other Working Capital | -830 | -5,737 | 769 | -2,136 | 3,656 |
| Other Operating Activity | 5,369 | 11,178 | 13,331 | 1,997 | 2,057 |
| Operating Cash Flow | $-9,961 | $-15,959 | $-21,339 | $-19,425 | $-21,056 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,093 | -557 | -944 | -580 | -814 |
| Net Acquisitions | N/A | N/A | -5,849 | N/A | N/A |
| Other Investing Activity | -750 | -1,240 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,843 | $-1,797 | $-6,793 | $-580 | $-814 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 43,340 | 40,329 | 29,517 | 23,844 | 20,228 |
| Debt Repayment | -37,848 | -35,314 | -29,537 | -21,300 | -16,128 |
| Common Stock Issued | 10,007 | 22,434 | 16,183 | 34,624 | 8,205 |
| Common Stock Repurchased | N/A | N/A | N/A | -14 | N/A |
| Other Financing Activity | 87 | -104 | 0 | -201 | -215 |
| Financing Cash Flow | $15,586 | $27,345 | $16,163 | $36,953 | $12,090 |
| Beginning Cash Position | 17,401 | 7,812 | 19,781 | 2,833 | 12,613 |
| End Cash Position | 21,183 | 17,401 | 7,812 | 19,781 | 2,833 |
| Net Cash Flow | $3,782 | $9,589 | $-11,969 | $16,948 | $-9,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,961 | -15,959 | -21,339 | -19,425 | -21,056 |
| Capital Expenditure | -1,093 | -559 | -965 | -580 | -849 |
| Free Cash Flow | -11,054 | -16,518 | -22,304 | -20,005 | -21,905 |